Production (Stage)
Johnson & Johnson
JNJ
$152.94
$0.330.22%
NYSE
| 03/30/2025 | 12/29/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.78% | 0.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.78% | 0.22% | |||
| Cost of Revenue | 4.94% | 2.23% | |||
| Gross Profit | -6.20% | -0.65% | |||
| SG&A Expenses | -20.00% | 18.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.15% | 8.67% | |||
| Operating Income | 57.49% | -25.79% | |||
| Income Before Tax | 250.68% | 16.45% | |||
| Income Tax Expenses | 477.19% | -29.19% | |||
| Earnings from Continuing Operations | 220.58% | 27.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 220.58% | 27.36% | |||
| EBIT | 57.49% | -25.79% | |||
| EBITDA | 37.20% | -18.64% | |||
| EPS Basic | 223.23% | 26.32% | |||
| Normalized Basic EPS | 65.67% | -31.07% | |||
| EPS Diluted | 221.71% | 27.14% | |||
| Normalized Diluted EPS | 64.55% | -30.48% | |||
| Average Basic Shares Outstanding | -0.82% | 0.83% | |||
| Average Diluted Shares Outstanding | -0.14% | -0.03% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.69% | -0.22% | |||